Inbiomotion

Inbiomotion

Inbiomotion

Inbiomotion is a personalized medicine company developing biomarkers that can predict bone metastasis in cancers.
Founded
2010
Raised
$4.7M
Follow us
Alexa global traffic share
Latest funding
$2,200,000
Venture capital (Series B) - 2016
Ysios Capital Caixa Innvierte BioMed II Fundación Vila Casas
$2,492,429
Venture capital (Series A) - 2012
Team Size
2
Employees
$2,200,000 Venture capital (Series B)
FinSMEs

Inbiomotion Raises €2.2M in Funding

Health Science